NeuroOne Medical Technologies Corp NMTC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $2.37
- Day Range
- $2.26–2.42
- 52-Week Range
- $2.26–6.96
- Bid/Ask
- $2.26 / $2.34
- Shares Outstanding
- 8.70M
- Market Cap
- $20.36M
- Volume/Avg
- 44,544 / 41,725
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.02
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 18
- Website
- https://www.n1mtc.com
Valuation
|
Metric
|
NMTC
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 3.75 |
Price/Sales | 2.02 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
NMTC
|
|---|---|
Quick Ratio | 3.10 |
Current Ratio | 4.38 |
Interest Coverage | −743.24 |
Quick Ratio
NMTC
Profitability
|
Metric
|
NMTC
|
|---|---|
Return on Assets (Normalized) | −68.03% |
Return on Equity (Normalized) | −102.71% |
Return on Invested Capital (Normalized) | −97.96% |
Return on Assets
NMTC
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|<Ss&$#G | LOCK|y#!! | $175B | |||
| Stryker Corp
SYK
| LOCK|?pMSsz% | LOCK|h!x | $123B | |||
| Medtronic PLC
MDT
| LOCK|ySlP$>$ | LOCK|@r^f | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|@bp<bf@ | LOCK|xNv> | $65B | |||
| Edwards Lifesciences Corp
EW
| LOCK|<#mQKpR% | LOCK|yG^p | $49B | |||
| DexCom Inc
DXCM
| LOCK|XTwL$WDK | LOCK|jC!R | $30B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|Ry%$H& | LOCK|%hw | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|bY& | LOCK|^<w | $26B | |||
| Steris PLC
STE
| LOCK|NpzgZ%$ | LOCK|gj$! | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|H>L#B^#w | LOCK|Rrq | $18B |
United States